Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
BMC Biotechnol ; 13: 68, 2013 Aug 30.
Article in English | MEDLINE | ID: mdl-24128347

ABSTRACT

BACKGROUND: The yeast Saccharomyces cerevisiae can be a useful model for studying cellular mechanisms related to sterol synthesis in humans due to the high similarity of the mevalonate pathway between these organisms. This metabolic pathway plays a key role in multiple cellular processes by synthesizing sterol and nonsterol isoprenoids. Statins are well-known inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the key enzyme of the cholesterol synthesis pathway. However, the effects of statins extend beyond their cholesterol-lowering action, since inhibition of HMGR decreases the synthesis of all products downstream in the mevalonate pathway. Using transgenic yeast expressing human HMGR or either yeast HMGR isoenzyme we studied the effects of simvastatin, atorvastatin, fluvastatin and rosuvastatin on the cell metabolism. RESULTS: Statins decreased sterol pools, prominently reducing sterol precursors content while only moderately lowering ergosterol level. Expression of genes encoding enzymes involved in sterol biosynthesis was induced, while genes from nonsterol isoprenoid pathways, such as coenzyme Q and dolichol biosynthesis or protein prenylation, were diversely affected by statin treatment. Statins increased the level of human HMGR protein substantially and only slightly affected the levels of Rer2 and Coq3 proteins involved in non-sterol isoprenoid biosynthesis. CONCLUSION: Statins influence the sterol pool, gene expression and protein levels of enzymes from the sterol and nonsterol isoprenoid biosynthesis branches and this effect depends on the type of statin administered. Our model system is a cheap and convenient tool for characterizing individual statins or screening for novel ones, and could also be helpful in individualized selection of the most efficient HMGR inhibitors leading to the best response and minimizing serious side effects.


Subject(s)
Hydroxymethylglutaryl CoA Reductases/metabolism , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Mevalonic Acid/metabolism , Saccharomyces cerevisiae/metabolism , Atorvastatin , Fatty Acids, Monounsaturated/pharmacology , Fluorobenzenes/pharmacology , Fluvastatin , Fungal Proteins/metabolism , Heptanoic Acids/pharmacology , Humans , Hydroxymethylglutaryl CoA Reductases/genetics , Indoles/pharmacology , Isoenzymes/metabolism , Organisms, Genetically Modified , Pyrimidines/pharmacology , Pyrroles/pharmacology , Rosuvastatin Calcium , Saccharomyces cerevisiae/growth & development , Simvastatin/pharmacology , Sterols/biosynthesis , Sulfonamides/pharmacology , Terpenes/metabolism
2.
PLoS One ; 8(9): e74187, 2013.
Article in English | MEDLINE | ID: mdl-24073201

ABSTRACT

The ADP/ATP carrier protein (AAC) expressed in Artemia franciscana is refractory to bongkrekate. We generated two strains of Saccharomyces cerevisiae where AAC1 and AAC3 were inactivated and the AAC2 isoform was replaced with Artemia AAC containing a hemagglutinin tag (ArAAC-HA). In one of the strains the suppressor of ΔAAC2 lethality, SAL1, was also inactivated but a plasmid coding for yeast AAC2 was included, because the ArAACΔsal1Δ strain was lethal. In both strains ArAAC-HA was expressed and correctly localized to the mitochondria. Peptide sequencing of ArAAC expressed in Artemia and that expressed in the modified yeasts revealed identical amino acid sequences. The isolated mitochondria from both modified strains developed 85% of the membrane potential attained by mitochondria of control strains, and addition of ADP yielded bongkrekate-sensitive depolarizations implying acquired sensitivity of ArAAC-mediated adenine nucleotide exchange to this poison, independent from SAL1. However, growth of ArAAC-expressing yeasts in glycerol-containing media was arrested by bongkrekate only in the presence of SAL1. We conclude that the mitochondrial environment of yeasts relying on respiratory growth conferred sensitivity of ArAAC to bongkrekate in a SAL1-dependent manner.


Subject(s)
Artemia/metabolism , Bongkrekic Acid/pharmacology , Drug Resistance, Fungal , Mitochondrial ADP, ATP Translocases/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Adenosine Diphosphate/metabolism , Adenosine Triphosphate/metabolism , Animals , Anti-Bacterial Agents/pharmacology , Artemia/drug effects , Artemia/growth & development , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondrial ADP, ATP Translocases/genetics , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics
3.
Postepy Biochem ; 58(3): 344-52, 2012.
Article in Polish | MEDLINE | ID: mdl-23373419

ABSTRACT

Mitochondria are organelles present in all eukaryotic organisms. Their primary function is production of energy in the form of ATP by oxidative phosphorylation. The final step of this process is catalyzed by an enzyme of internal mitochondrial membrane - ATP synthase. The ATP synthase consists of the seventeen subunits in yeast (in vertebrate sixteen is identified to date) organized in hydrophobic, membrane localized unit, referred to as F0 and hydrophilic domain F1 directed into mitochondria matrix. Genes encoding the ATP synthase subunits are mainly nuclear, but few of them, encoding hydrophobic subunits, are retained in mitochondrial genome in most Eukaryotes. Biogenesis of the ATP synthase is a sophisticated process, depending on the activity of proteins, which are not ATP synthase subunits, coordinating expression of the nuclear and mitochondrial genes and their assembly in active complex. This review summarizes the present knowledge about structure, biogenesis and mechanism of ATP synthase complex function.


Subject(s)
Mitochondrial Proton-Translocating ATPases/chemistry , Mitochondrial Proton-Translocating ATPases/metabolism , Humans , Mitochondrial Proton-Translocating ATPases/genetics , Oxidative Phosphorylation
4.
Eur J Cell Biol ; 90(10): 834-43, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21868125

ABSTRACT

The Rsp5 ubiquitin ligase regulates numerous cellular processes. Rsp5 is mainly localized to the cytoplasm but nuclear localization was also reported. A potential nuclear export signal was tested for activity by using a GFP(2) reporter. The 687-LIGGIAEIDI-696 sequence located in the Hect domain was identified as a nuclear export signal active in a Crm1-dependent manner, and its importance for the localization of Rsp5 was documented by using fluorescence microscopy and a lacZ-based reporter system. Analysis of the cellular location of other Rsp5 fragments fused with GFP(2) indicated two independent potential nuclear localization signals, both located in the Hect domain. We also uncovered Rsp5 fragments that are important to targeting/tethering Rsp5 to various regions in the cytoplasm. The presented data indicate that Rsp5 ligase is a shuttling protein whose distribution within the cytoplasm and partitioning between cytoplasmic and nuclear locations is determined by a balance between the actions of several targeting sequences and domains.


Subject(s)
Endosomal Sorting Complexes Required for Transport/metabolism , Nuclear Export Signals/genetics , Nuclear Localization Signals/genetics , Protein Transport , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Ubiquitin-Protein Ligase Complexes/metabolism , Amino Acid Sequence , Cell Nucleus/metabolism , Endosomal Sorting Complexes Required for Transport/chemistry , Endosomal Sorting Complexes Required for Transport/genetics , Gene Knockout Techniques , Genes, Reporter , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Karyopherins/genetics , Karyopherins/metabolism , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Protein Structure, Tertiary , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Cytoplasmic and Nuclear/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Ubiquitin-Protein Ligase Complexes/chemistry , Ubiquitin-Protein Ligase Complexes/genetics , Exportin 1 Protein
5.
Protein Expr Purif ; 71(1): 28-32, 2010 May.
Article in English | MEDLINE | ID: mdl-20093188

ABSTRACT

Plasma retinol-binding protein (RBP4) is the principal carrier of vitamin A in blood. Recent studies have suggested that RBP4 may have also a role in insulin resistance. To date the recombinant protein is usually produced by refolding inclusion bodies in Escherichia coli. Here we report the expression and characterization of recombinant human plasma RBP4 using the Pichia pastoris expression system. Simple and rapid purification allowed us to obtain 5mg/L of purified protein from the fermentation supernatant with no need to perform denaturing and refolding steps. The identity of the protein was verified by ion-trap MS and Western blotting. The functionality of recombinant RBP4, i.e., the binding to its physiologic ligand, retinol, and the interaction with transthyretin (TTR), was tested by fluorimetric and pull-down assays, respectively. The apparent dissociation constant for retinol to the recombinant protein of 2 x 10(-7)M was consistent with published data for native human protein. The recombinant protein interacted specifically with TTR. These results suggest that expression of recombinant human RBP4 in P. pastoris provides an efficient source of fully functional protein in soluble form for biochemical and biophysical studies.


Subject(s)
Biochemistry/methods , Pichia/metabolism , Recombinant Proteins/metabolism , Retinol-Binding Proteins, Plasma/metabolism , Amino Acid Sequence , Biological Assay , Humans , Mass Spectrometry , Molecular Sequence Data , Prealbumin/metabolism , Protein Binding , Recombinant Proteins/isolation & purification , Retinol-Binding Proteins, Plasma/chemistry , Retinol-Binding Proteins, Plasma/isolation & purification , Time Factors , Vitamin A/metabolism
6.
Eur Biophys J ; 39(4): 679-88, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19921174

ABSTRACT

Peripherin/RDS is a member of the tetraspanin family of integral membrane proteins and plays a major role in the morphology of photoreceptor outer segments. Peripherin/RDS has a long extracellular loop (hereafter referred to as the LEL domain), which is vital for its function. Point mutations in the LEL domain often lead to impaired photoreceptor formation and function, making peripherin/RDS an important drug target. Being a eukaryotic membrane protein, acquiring sufficient peripherin/RDS for biophysical characterisation represents a significant challenge. Here, we describe the expression and characterisation of peripherin/RDS in Drosophila melangolaster Schneider (S2) insect cells and in the methylotrophic yeast Pichia pastoris. The wild-type peripherin/RDS and the retinitis pigmentosa causing P216L mutant from S2 cells are characterised using circular dichroism (CD) spectroscopy. The structure of peripherin/RDS and of a pathogenic mutant is assessed spectroscopically for the first time. These findings are evaluated in relation to a three-dimensional model of the functionally important LEL domain obtained by protein threading.


Subject(s)
Intermediate Filament Proteins/chemistry , Intermediate Filament Proteins/genetics , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/genetics , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/genetics , Retinal Photoreceptor Cell Outer Segment/metabolism , Amino Acid Sequence , Animals , Cells, Cultured , Circular Dichroism , Drosophila melanogaster/cytology , Drosophila melanogaster/genetics , Electrophoresis, Polyacrylamide Gel , Gene Expression , Humans , Intermediate Filament Proteins/biosynthesis , Intermediate Filament Proteins/metabolism , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/metabolism , Models, Molecular , Molecular Sequence Data , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/metabolism , Peripherins , Pichia/genetics , Point Mutation , Protein Structure, Tertiary , Spectrum Analysis
7.
PLoS One ; 4(12): e8499, 2009 Dec 30.
Article in English | MEDLINE | ID: mdl-20041128

ABSTRACT

In humans, defects in lipid metabolism are associated with a number of severe diseases such as atherosclerosis, obesity and type II diabetes. Hypercholesterolemia is a primary risk factor for coronary artery disease, the major cause of premature deaths in developed countries. Statins are inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the key enzyme of the sterol synthesis pathway. Since yeast Saccharomyces cerevisiae harbours many counterparts of mammalian enzymes involved in lipid-synthesizing pathways, conclusions drawn from research with this single cell eukaryotic organism can be readily applied to higher eukaryotes. Using a yeast strain with deletions of both HMG1 and HMG2 genes (i.e. completely devoid of HMGR activity) with introduced wild-type or mutant form of human HMGR (hHMGR) gene we investigated the effects of statins on the lipid metabolism of the cell. The relative quantification of mRNA demonstrated a different effect of simvastatin on the expression of the wild-type and mutated hHMGR gene. GC/MS analyses showed a significant decrease of sterols and enhanced conversion of squalene and sterol precursors into ergosterol. This was accompanied by the mobilization of ergosterol precursors localized in lipid particles in the form of steryl esters visualized by confocal microscopy. Changes in the level of ergosterol and its precursors in cells treated with simvastatin depend on the mutation in the hHMGR gene. HPLC/MS analyses indicated a reduced level of phospholipids not connected with the mevalonic acid pathway. We detected two significant phenomena. First, cells treated with simvastatin develop an adaptive response compensating the lower activity of HMGR. This includes enhanced conversion of sterol precursors into ergosterol, mobilization of steryl esters and increased expression of the hHMGR gene. Second, statins cause a substantial drop in the level of glycerophospholipids.


Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Lipid Metabolism/drug effects , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , Chromatography, Thin Layer , Gas Chromatography-Mass Spectrometry , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Fungal/drug effects , Humans , Hydroxymethylglutaryl CoA Reductases/genetics , Hydroxymethylglutaryl CoA Reductases/metabolism , Microscopy, Confocal , Mutant Proteins/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Simvastatin/pharmacology , Squalene/metabolism , Staining and Labeling , Sterols/metabolism
8.
FEBS Lett ; 581(28): 5371-6, 2007 Nov 27.
Article in English | MEDLINE | ID: mdl-17967424

ABSTRACT

Pan1 is an actin patch-associated protein involved in endocytosis. Our studies revealed that in oleate-grown cells Pan1 is located in the nucleus as well as in patches. One of three putative nuclear localization signals (NLS) of Pan1, NLS2, directed beta-galactosidase (beta-gal) to the nucleus. However, GFP-Pan1(886-1219), containing NLS2, was found in the cytoplasm indicating that it may contain a nuclear export signal (NES). A putative Pan1 NES, overlapping with NLS3, re-addressed NLS(H2B)-NES/NLS3-beta-gal from the nucleus to the cytoplasm. Inactivation of the NES allowed NLS3 to be effective. Thus, Pan1 contains functional NLSs and a NES and appears to shuttle in certain circumstances.


Subject(s)
Cell Nucleus/metabolism , Fungal Proteins/metabolism , Nuclear Export Signals , Saccharomyces cerevisiae/metabolism , Active Transport, Cell Nucleus , Fungal Proteins/chemistry , Fungal Proteins/genetics , Genes, Reporter/genetics , Microfilament Proteins , Molecular Sequence Data , Saccharomyces cerevisiae/chemistry , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins
9.
Exp Cell Res ; 310(2): 482-92, 2005 Nov 01.
Article in English | MEDLINE | ID: mdl-16171804

ABSTRACT

Pan1p is a yeast actin cytoskeleton-associated protein localized in actin patches. It activates the Arp2/3 complex, which is necessary for actin polymerization and endocytosis. We isolated the pan1-11 yeast mutant unable to grow on oleate as a sole carbon source and, therefore, exhibiting the Oleate- phenotype. In addition, mutant cells are temperature-sensitive and grow more slowly on glycerol or succinate-containing medium but similarly to the wild type on ethanol, pyruvate or acetate-containing media; this indicates proper functioning of the mitochondrial respiratory chain. However, growth on ethanol medium is compromised when oleic acid is present. Cells show growth arrest in the apical growth phase, and accumulation of cells with abnormally elongated buds is observed. The growth defects of pan1-11 are suppressed by overexpression of the END3 gene encoding a protein that binds Pan1p. The morphology of peroxisomes and induction of peroxisomal enzymes are normal in pan1-11, indicating that the defect in growth on oleate medium does not result from impairment in peroxisome function. The pan1-11 allele has a deletion of a fragment encoding amino acids 1109-1126 that are part of (QPTQPV)7 repeats. Surprisingly, the independently isolated pan1-9 mutant, which expresses a truncated form of Pan1p comprising aa 1-859, is able to grow on all media tested. Our results indicate that Pan1p, and possibly other components of the actin cytoskeleton, are necessary to properly regulate growth of dividing cells in response to the presence of some alternative carbon sources in the medium.


Subject(s)
Fungal Proteins/genetics , Oleic Acid/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/genetics , Actins/chemistry , Actins/metabolism , Alleles , Cell Wall/genetics , Cell Wall/metabolism , Cell Wall/ultrastructure , Culture Media/metabolism , Cytoskeletal Proteins/chemistry , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Cytoskeleton/genetics , Cytoskeleton/metabolism , Endocytosis/genetics , Fungal Proteins/analysis , Fungal Proteins/metabolism , Microfilament Proteins , Mutation , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/analysis , Saccharomyces cerevisiae Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...